Prognostic impact of primary cancer adjoining emphysematous bullae in non-small cell lung cancer patients treated with immune checkpoint inhibitors.
Shinkichi TakamoriKazuki TakadaMototsugu ShimokawaMikako JinnnouchiTaichi MatsubaraNaoki HaratakeNaoko MiuraRyo ToyozawaMasafumi YamaguchiMitsuhiro TakenoyamaYasuto YoneshimaKentaro TanakaIsamu OkamotoTetsuzo TagawaMasaki MoriPublished in: Cancer immunology, immunotherapy : CII (2021)
Patients with Ca-ADJ may be good candidates for ICIs. These findings should be validated prospectively.